Publications by authors named "Hatoon Abbas"
Article Synopsis
- The American Association of Bronchology and Interventional Pulmonology aims to keep clinicians informed with brief, current reviews on essential interventional pulmonology topics, starting with malignant pleural disease.
- The article consists of three parts that update readers on malignant pleural effusion: diagnosis through imaging and fluid biomarkers, management strategies including multimodal approaches and targeted therapies, and details on pleural mesothelioma.
- These reviews are part of the Essential Knowledge series presented at the 2023 AABIP Annual Conference, and recorded lectures are available for access on the AABIP website.
Background: The mortality benefit of VV-ECMO in ARDS has been extensively studied, but the impact on long-term functional outcomes of survivors is poorly defined. We aimed to assess the association between ECMO and functional outcomes in a contemporaneous cohort of survivors of ARDS.
Methods: Multicenter retrospective cohort study of ARDS survivors who presented to follow-up clinic.
Incidental nodules and lung cancer screening nodules are causes of concern and anxiety for the patients. Both these require diligent follow up according to their respective guidelines.
View Article and Find Full Text PDFObjectives: To characterize the effect of racial and socioeconomic factors on the timeliness of lung cancer diagnosis and treatment in a single-center Veterans Affair Medical Center (VAMC) pulmonary nodule clinic.
Methods: We conducted a single-center retrospective review of all patients seen at the Baltimore VAMC pulmonary nodule clinic between 2013 and 2019 to identify key demographic factors, measures of neighborhood socioeconomic disadvantage, cancer staging and histopathologic information, and time elapsed between diagnosis and treatment. We excluded patients with pulmonary nodules undergoing active surveillance, prior history of lung cancer, metastases of a different primary origin, insufficient followup, or who had received care outside the VHA system.
Lung cancer screening begins at age 50, with yearly low dose computed tomography (LDCT) scans until age 80, for patients determined to be high risk due to tobacco smoking. Veterans serving from World War II to the Gulf War are now at the age where LDCT is recommended. This recommendation from the United States Preventative Service Task Force includes patients who have a 20-pack year tobacco history and currently smoke or quit within the last 15 years.
View Article and Find Full Text PDF